AI FOR SCIENCE · ON THE RECORD
Eli Lilly
Research on the record
- 2026-10-06insitro puts models trained on Lilly's decades of preclinical data into Lilly TuneLab, for member biotechs to predict how a molecule behaves in the body before making itLevel 2 · Computed
Graded by how far the evidence went, not how good the result is. See the methodology.
Also on the timeline
- 2026-10-19METiS TechBio will design lipids for Eli Lilly with its own AI platform, under a collaboration worth up to about $1.1B in milestonesPartnerships
- 2026-09-05Superluminal Medicines, which designs GPCR drugs with machine learning and cryo-EM, raises a $60M Series B led by BVF Partners to take its first drug into the clinicCapital
- 2026-07-09Alchemab, which looks for antibodies in people who resist disease, adds a GBP 25M Series A extension from the British Business Bank, the bank's largest life sciences investmentCapital
- 2026-04-28Lilly will license recombinases Profluent is to design with AI, enzymes for writing long DNA into the genome: upfront undisclosed, up to $2.25B in milestonesPartnerships
- 2024-01-07Isomorphic Labs signs Lilly and Novartis collaborationsPartnerships
This page compiles what AI4S.fyi has recorded and links each item to its source. It is not a grade of the organization and not its complete history: a blank means the record has not caught up as often as it means nothing happened.